1. Home
  2. MLEC vs GDTC Comparison

MLEC vs GDTC Comparison

Compare MLEC & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$0.24

Market Cap

2.6M

Sector

Finance

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.32

Market Cap

16.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLEC
GDTC
Founded
2008
2018
Country
Cayman Islands
Singapore
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
16.9M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
MLEC
GDTC
Price
$0.24
$1.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
382.7K
41.7K
Earning Date
01-30-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$573,193.00
Revenue This Year
$20.42
$5.37
Revenue Next Year
$30.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
170.36
63.03
52 Week Low
$0.21
$1.29
52 Week High
$8.00
$4.05

Technical Indicators

Market Signals
Indicator
MLEC
GDTC
Relative Strength Index (RSI) 30.35 31.87
Support Level $0.21 $1.29
Resistance Level $0.32 $1.60
Average True Range (ATR) 0.05 0.10
MACD -0.00 -0.01
Stochastic Oscillator 11.19 12.82

Price Performance

Historical Comparison
MLEC
GDTC

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: